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Abstract
The aim of the present study was to investigate the role of CAG repeat polymorphism and X-chromosome Inactivation (XCI)
pattern in Recurrent Spontaneous Abortions among Indian women which has not been hitherto explored. 117 RSA cases
and 224 Controls were included in the study. Cases were recruited from two different hospitals - Lakshmi Fertility Clinic,
Nellore and Fernandez Maternity Hospital, Hyderabad. Controls were roughly matched for age, ethnicity and socioeconomic
status. The CAG repeats of the Androgen Receptor gene were genotyped using a PCR-based assay and were analysed using
the GeneMapper software to determine the CAG repeat length. XCI analysis was also carried out to assess the inactivation
percentages. RSA cases had a significantly greater frequency of allele sizes in the polymorphic range above 19 repeats
(p = 0.006), which is the median value of the controls, and in the biallelic mean range above 21 repeats (p = 0.002). We found
no evidence of abnormal incidence of skewed X-inactivation. We conclude that longer CAG repeat lengths are associated
with increased odds for RSA with statistical power estimated to be ,90%.
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Introduction
Recurrent Spontaneous Abortions (RSA) of unknown aetiology
provide fundamental insights into the processes of embryogenesis
and implantation and is also a frustrating and emotionally charged
clinical problem. Spontaneous Abortion is one of the least
understood pathological processes in spite of being one of the
most common symptoms. Hormonal factors have been proposed
to contribute to RSA [1,2]. Hormonal aberrations may result from
problems with certain endocrine glands, such as the pituitary,
thyroid, adrenal and the ovaries. An increased miscarriage rate has
been observed in women with polycystic ovarian disease, a
disorder which is characterized by amenorrhoea, hirsutism, and
raised androgen concentrations [1,3]. The prevalence of polycystic
ovarian syndrome (PCOS) in women with recurrent spontaneous
abortion has been reported to be between 44% [1] and 82% [3].
Further, abnormalities in androgen secretion during the follicular
phase, and hyperandrogenism have been associated with sponta-
neous abortions, suggesting an endocrine aetiology to this disorder
[2]. At the molecular level, the effect of androgens is mediated
through the activation of androgen receptor (AR). The human
androgen receptor encoded in the X-chromosome contains a
highly polymorphic CAG repeat sequence within exon 1. In vitro
studies showed an inverse relation between number of CAG
repeats in the AR gene and AR activity [4], and a number of
clinical conditions, including infertility, have been attributed to the
resulting variation in androgen activity has been cited by Mifsud
et al. (2000) [5]. Few studies have found association of CAG
repeats of the AR gene in PCOS [5–8] while many others did not
[9–15]. But such investigations among RSA cases have not been
hitherto conducted. Since AR gene lies on the X-chromosome, it
becomes pertinent to assess the X chromosome Inactivation (XCI)
pattern as well. There have been several studies where X-
Inactivation patterns have been assessed in the RSA cases [16–22],
particularly skewed XCI patterns, which suggest transmission of
X-linked recessive lethal traits. However, the results are essentially
confounding, while some studies reported association of skewed X-
inactivation with RSA [16–18], others did not. Moreover, such
studies have only been restricted to assess the skewed XCI pattern
independent of the CAG repeat polymorphism among RSA
women. Given the variation in the CAG repeat length of the
androgen receptor (AR) gene and its inverse effect on the receptor
activity, the alleles with longer CAG repeat length are expected to
result in diminished androgen receptor activity, which might lead
to a state of biochemical hyperandrogenism, i.e. increased serum
levels of androgens as demonstrated in a couple of previous studies
[5,7]. Previous studies have reported hyperandrogenism to be
associated with RSA where they have demonstrated elevated levels
of androgens among RSA women in contrast to the controls [1,2].
Therefore, the present study was undertaken to investigate the
possible role of the CAG repeat polymorphism and the XCI
pattern in the manifestation of RSA in the southern Indian women
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17718
with the underlying hypothesis that longer CAG repeat length
(resulting in hyperandrogenemia) would be associated with RSA.
Materials and Methods
Samples
Intravenous blood samples (,5 ml) were collected from 117
RSA women with unknown aetiology, recruited from two different
hospitals - 71 RSA cases from Lakshmi Fertility Clinic (LFC) in
sub urban Nellore town and 46 RSA cases from Fernandez
Maternity Hospital (FMH) in metropolitan Hyderabad. Blood
samples from 224 control women, representing similar age,
ethnicity and socioeconomic status as compared to cases, were
drawn from general population of the respective areas (120 from
Nellore and 104 from Hyderabad).
Recurrent Spontaneous Abortions (RSA) is defined as repeated
occurrence of 3 or more miscarriages before 24th week of
gestation [23]. The modern definition, however, is the spontane-
ous loss of 2 or more consecutive pregnancies before 20 weeks of
gestation [24,25]. Following the latest definition, women with $2
spontaneous abortions were included for the study. Other
inclusion criteria considered for recruitment of cases were normal
findings for: karyotype, anatomical features, tissue antibodies and
auto antibodies, blood glucose levels and thyroid stimulating
hormone concentrations and with no recent history of infectious
aetiology. All the RSA women, with the mean age of 26 yrs (range
18–37 years of age) and number of miscarriages ranging between 2
and 9, had regular menstrual cycles and were healthy. Normal
fertile controls with no history of abortions or treatment for fertility
and with normal menstrual cycles every 25–32 days were recruited
from the family planning centre of the Osmania hospital,
Hyderabad and from the general population. The sampled
subjects speak Telugu and the populations of these areas in
Andhra Pradesh are observed to be genetically homogeneous [26].
Ethics Statement
The samples were collected with written informed consent of all
the subjects, cases as well as controls. This study has been
approved by the Indian Statistical Institute Review Committee for
Protection of Research Risks to Humans.
DNA extraction, amplification and Genescan analysis
DNA was extracted from the peripheral blood samples of the
patients and controls using the phenol-chloroform method [27].
The CAG repeats were genotyped using a PCR-based assay.
Genomic DNA was amplified by PCR using fluorescently labelled
primers that flank the CAG repeats [28]. The forward primer was
labelled at the 59end with the dye 6FAM. Amplification was
carried out in a GeneAmp9700 thermal cycler (Applied Biosys-
tems, Foster City, CA) as previously described [28]. The amplified
products were separated on a denaturing polyacrylamide gel using
an ABI 3730 genetic analyzer (Applied Biosystems, Foster City,
CA). The fragment size was estimated by comparison with the
internal size standard GS-LIZ500.
X-Chromosome inactivation analysis
X inactivation analysis was carried out using the protocol given
by Hickey et al. (2002)[7]. For the 341 heterozygous subjects,
100 ng of DNA were either digested with 1U of HpaII or
incubated in digestion buffer alone at 37uC overnight, followed by
incubation at 95uC for 5 min to denature the enzyme. Next, 1 ml
of digested and mock-digested products were amplified using PCR
primers given by Cram et al. (2000) [28] and peak areas of both
the alleles were determined using an ABI 3730 genetic analyzer
and Genemapper (version 3.7, Applied Biosystems). X inactivation
(relative methylation of each allele) was quantified as previously
described by Hickey et al. (2002) [7], comparing the ratio to which
each allele contributed to the total peak area between digested and
undigested samples.
The X-Inactivation percentages are expressed in terms of
degree of inactivation of the longer allele. Nonrandom X
inactivation is defined as more than 60% inactivation of either
allele; skewed X inactivation is defined as more than 80%
inactivation of either allele. Following X-Inactivation analysis, we
calculated X-weighted biallelic means as per the protocol given by
Hickey et al. (2002) [7], whereby each allele in a genotypic pair is
multiplied by its percent activation, and the two adjusted repeat
values are added together.
Statistical Analysis
The number of different CAG repeats constitutes the different
alleles in the sample. Frequency of each of these repeat lengths is
considered to be the allele frequencies. x2 analysis was done to test
for the homogeneity of allele frequencies between the cases and
controls. Logistic regression analysis was done and odds ratios
obtained for perceived risk alleles (alleles which were observed to
have relatively greater frequency among the RSA cases than the
controls in the present study, i.e. CAG repeat size of .19 and
CAG biallelic mean of $21) to check if significant association can
be found with RSA. All the statistical analyses were performed
with the help of SPSS statistical software (version 15.0, SPSS Inc,
Chicago, IL, USA). For all tests, significance was set at 5%. Power
Analysis of the logistic regression was carried out using G*Power
(version 3.1.0, Germany).
Results
CAG allele distribution
In our cohort of 117 RSA women and 224 controls, the
androgen receptor CAG repeats ranged from 5–30 and 9–31,
respectively (Fig. 1). The mean number of CAG repeats for the
cases (19.060.23) and controls (18.7660.13) is similar. The
median value of the CAG repeats is 20 for the cases and 19 for
controls. For qualitative comparisons, the median value of 19
repeats observed for controls is considered, which bisects the entire
polymorphic range providing three categories viz. ,19, 19 and
.19 repeats. The CAG allele distribution pattern of the RSA
cases and controls is depicted in Figure 1. The allele distribution in
the above three categories (Fig. 2) suggests significantly greater
frequency of RSA cases in the .19 CAG repeat category
(p = 0.0006). We also obtained a significant difference in the
biallelic mean distribution pattern (Fig. 3) between the RSA cases
and controls (p = 0.03) with the cases being more frequent in the
upper polymorphic range. The frequency distribution of the RSA
and control women in the three qualitative categories, bearing
repeat values at the median, below and above the control median
are presented in Table 1 for the total alleles (2N) and biallelic
mean and in Table 2 for longer and shorter alleles separately.
When the biallelic mean is categorised into ,21 and $21 repeats,
the RSA women were observed to be in a significantly higher
frequency in the $21 repeat category (p= 0.002).
The case cohort was additionally analysed according to the
number of abortions experienced by the subjects. The distribution
of the CAG biallelic mean in different abortion categories is
provided in Table S1. The case cohort was further divided into 2
groups: (i) cases with 2 abortions, and (ii) cases with 3 or more
abortions. Allele frequency distribution was compared between
these two groups and each of these groups with controls for
AR CAG Repeats and XCI in RSA
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biallelic mean and for both longer and shorter alleles separately.
The x2 analysis revealed significant heterogeneity in the biallelic
mean distribution for each of the two abortion categories when
compared with the controls (p = 0.013, p= 0.0007) as well as in the
distribution of longer alleles between the RSA group with $3
abortions and the controls (p = 0.002) (Figure S1).
Logistic Regression
Given the significant heterogeneity in the biallelic mean
frequency between the RSA cases and the controls, odds ratio
was also computed to examine if there is any effect of repeat
numbers in the upper polymorphic range of the allele spectrum in
the manifestation of RSA. Odds were computed for the CAG
repeats .19 VS#19 for the total alleles and $21 VS,21 for the
biallelic mean, considering the entire cohort and the two abortion
categories separately with the controls (Table 3). Highly significant
odds were obtained for each of the categories suggesting strong
association of extreme CAG repeat lengths with RSA. Bonferroni
correction for multiple testing was carried out for the logistic
regression analysis. Except the RSA group with 2 abortions versus
controls, all the other three categories show significant differences
even after the correction.
Regression analysis of each of the categories was subjected to
post-hoc power analysis, which was carried out using G*Power
Figure 1. Distribution of CAG alleles in RSA cases and controls.
doi:10.1371/journal.pone.0017718.g001
Figure 2. Frequency distribution of CAG alleles, grouped into 3 categories of ,19, 19 and .19 CAG repeats, in RSA cases and
controls.
doi:10.1371/journal.pone.0017718.g002
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software (version 3.1.0, Germany). Statistical power (1-b error
probability) is computed as a function of significance level a,
sample size, and population effect size (also defined by the odds
ratio under the logistic regression criteria). Since the logistic
regression results are being considered for power calculation, the
conditional probability of the dependent variable Y and
independent variable X under null hypothesis (H0) is also
furnished as the input parameter denoted by Pr(Y=1|X=1)H0.
Given our samples and setting a value at 0.05, we obtained very
high power for our study (Table 4). We repeated the logistic
regression and power analysis by selecting a 60% random
subsample of the controls that results into similar sample size as
that of the cases (results not presented), which yielded very similar
results, qualitatively and quantitatively.
Internal Consistency
The RSA cases in our study were recruited from two hospitals:
Lakshmi Fertility Clinic & Research Centre (LFC) and Fernandez
Hospital (FMH). These two hospitals not only represent two
different socioeconomic strata of the patients, but are also
separated geographically by about 500 kms. The socio-economic
status, which was assessed by taking into account the social
hierarchy and occupational status reflecting the income patterns, is
expected to affect the nutritional status of the individual and in
turn the pregnancy outcome [29–32]. While the patients visiting
FMH are from an urban background, and most of the patients fall
into the middle or high income groups, the patients from LFC are
from the semi urban and rural backgrounds and fall into middle
and lower income categories. Therefore, in order to check for the
internal consistency of our data, we analysed case samples from
each of these hospitals separately with independent random
subsamples of controls of comparable size to that of the respective
case samples. Frequencies of the qualitative CAG repeat lengths
(,19, 19 and .19 repeats) were compared in two groups: (i) RSA
cases from FMH (N=46) versus controls (N= 68) (subsample 1)
and (ii) RSA cases from LFC (N=71) versus controls (N= 87)
(subsample 2). Concurrent to the pattern observed in the case of
pooled sample, we found significantly greater frequency of RSA
cases in the longer CAG repeat length category (.19 repeats)
consistently in the two hospital specific analyses; while 57.6% of
RSA cases had .19 CAG repeats as compared to 38.9% in
controls in the case of FMH (x2=9.88, df = 2, p = 0.007), 47.8%
of RSA cases had .19 CAG repeats as compared to 40.2% in
controls (x2 = 6.19, df = 2, p= 0.045) in the case of LFC (Results
not presented). The logistic regression analysis was further
performed on each of the two hospital specific samples, which
yielded significant odds ratios; CAG repeat length of .19 was
associated with increased odds of RSA in each of the two samples
Figure 3. Distribution of CAG biallelic mean in RSA cases and controls.
doi:10.1371/journal.pone.0017718.g003
Table 1. Distribution (%) of RSA cases and controls according
to the qualitative categories of CAG repeats.
Repeat size Total number of CAG alleles CAG Biallelic Mean
Cases
(2N=234)
Controls
(2N=448)
Cases
(N=117)
Controls
(N=224)
,19 42.7 45.1 47.0 47.7
19* 5.5 14.2 8.9 9.4
.19 51.7 40.6 43.5 43.3
*Control median
x2=14.81, df = 2, p=0.0006; x2 = 0.29, df = 2, p = 0.985.
doi:10.1371/journal.pone.0017718.t001
Table 2. Distribution (%) of RSA cases and controls according
to the qualitative categories of shorter and longer CAG
repeats alleles (in an individual).
Repeat
size
(i) Shorter
CAG alleles
Repeat
size
(ii) Longer
CAG alleles
Cases
(N=117)
Controls
(N=224)
Cases
(N=117)
Controls
(N=224)
,17 38.4 36.6 ,21 43.5 53.1
17* 16.2 15.2 21* 21.3 16.5
.17 45.2 48.2 .21 35.0 30.3
*Control Median
x2= 0.264, df = 2, p = 0.875; x2 = 2.923, df = 2, p = 0.231.
doi:10.1371/journal.pone.0017718.t002
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(OR=2.12, p = 0.006 and OR=2.94, p= 0.015) albeit after
Bonferroni correction, only the subsample 1 show significant
association The detailed results for logistic regression analysis of
these two categories are provided in Supplementary tables Table
S2 and Table S3.
X chromosome inactivation (XCI) analysis
Analysis for X-chromosome inactivation revealed that majority
of the cohort (71% of the RSA cases and 65% of the controls)
follow random (,60%) X-inactivation pattern (Figure 4). We
found no evidence of abnormal incidence of skewed X-inactivation
(alleles$80% inactive) in either group (7.6% controls, 2.5% RSA),
which is comparable to previously published studies [19–22].
X_weighted_biallelic mean, which was calculated by incorporat-
ing XCI percentages, also did not show any difference between
cases and controls, hence no perceptible epigenetic influence can
be deduced. The frequency distribution of the RSA and control
women in the three qualitative categories, bearing repeat values at
the median, below and above the control median is presented for
X-weighted biallelic mean in Table 5. Allele frequency distribution
was also compared between the two abortion groups and each of
these groups with controls for X-weighted biallelic mean.
However, none of these analyses yielded significant results to
suggest epigenetic influence. Though we observed random XCI
pattern for majority of the cases and controls, the X_weight-
ed_biallelic distribution (Figure S2) depicts that the longer alleles
are relatively more frequently active among the RSA cases
compared to the controls.
Discussion
To the best of our knowledge, this is the first study that has
examined the Androgen Receptor exon 1 CAG repeat variation
in RSA. Our findings indicate that RSA women have a
significantly greater frequency of longer AR CAG alleles (.19
repeats) and biallelic means ($21 repeats) than fertile control
women. The longer CAG repeat lengths were associated with
increased odds of RSA. A number of earlier studies have
focussed on the skewed X-Inactivation patterns among the RSA
women yielding conflicting results, [16–22] only 3 of the 7
studies reported association [16–18]. In our case, the overall X-
Inactivation pattern was not different between cases and
controls, hence no perceptible epigenetic influence, which is in
accordance to some of the previous studies where skewed XCI
could not be associated with RSA [19–22]. It is pertinent to note
that earlier investigations on the X-Inactivation patterns
primarily addressed the issue of identification of the X-linked
recessive lethal traits with the underlying genetic hypothesis that
carriers of the recessive lethal traits manifest the molecular
phenotype of non-random (skewed) X chromosome inactivation.
In addition to this, it was also proposed that a subset of these
lethal traits may cause an increased frequency of spontaneous
abortions in carriers if the hemizygous trait produces a clinically
detectable pregnancy [16].
Given the inverse relationship between the CAG repeat length
of the androgen receptor (AR) gene and the receptor activity, the
alleles with longer CAG repeat length are expected to show a state
of biochemical hyperandrogenism Infact previous studies have
Table 3. Results of logistic regression analysis for the extreme CAG repeat categories .19 VS#19 and $21 VS,21 in total allele
category (CAG RN) and for biallelic means (BAM), respectively.
Cases Controls x2 P-value Odds ratio 95% CI for Odds ratio
(no) % (no) % Lower Upper
aCAG RN .19 121 51.7 182 40.6 7.608 0.006** 1.56 1.13 2.15
aBAM$21 31 26.4 29 12.9 9.058 0.002** 2.42 1.37 4.27
bBAM$21 17 23.2 29 12.9 4.378 0.036* 2.04 1.04 3.98
cBAM$21 14 31.8 29 12.9 9.058 0.003** 3.14 1.49 6.61
aPooled RSA cases Vs Controls (For CAG RN, Cases: 2N = 234 Controls: 2N = 448; For BAM, Cases: N = 117 Controls: N = 224).
bRSA (2abortions) Vs Controls (Cases: N = 73 Controls: N = 224).
cRSA ($3abortions) Vs Controls (Cases: N = 44 Controls: N = 224).
*not significant after Bonferroni correction;
**Significant after Bonferroni correction.
doi:10.1371/journal.pone.0017718.t003
Table 4. Results of power analysis for different CAG allele categories used in the logistic regression alongwith the input
parameters.
Odds ratio Pr(Y=1|X=1) H0
a err prob
(P-value)
Total sample
size
Binomial distribution
parameter p Power (1-b)
aCAG RN .19 1.56 0.34 0.05 682 0.44 0.878
aBAM$21 2.42 0.34 0.05 341 0.18 0.997
bBAM$21 2.04 0.24 0.05 297 0.15 0.679
cBAM$21 3.14 0.16 0.05 268 0.16 0.916
aPooled RSA cases Vs Controls (For CAG RN, Cases: 2N = 234 Controls: 2N = 448; For BAM, Cases: N = 117 Controls: N = 224).
bRSA (2abortions) Vs Controls (Cases: N = 73 Controls: N = 224).
cRSA ($3abortions) Vs Controls (Cases: N = 44 Controls: N = 224).
doi:10.1371/journal.pone.0017718.t004
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reported hyperandrogenism to be associated with RSA where they
have demonstrated elevated levels of androgens among RSA
women in contrast to the controls [1,2]. Therefore, we tried to
examine the X-Inactivation patterns vis-a-vis the CAG repeat
polymorphism of the AR gene. Although we did not observe any
significant epigenetic influence, we could establish strong genetic
association of CAG repeat length (.19 in case of total alleles and
$21 in case of biallelic mean) with RSA yielding highly significant
odds ratio with adequate statistical power (,90%) conforming to
our hypothesis. However, since the epigenetic influence was
examined using peripheral blood samples in the present study and
given that there are great variations in the degree of X-inactivation
between ages and tissues [33], it thus becomes imperative to study
the tissue specific XCI patterns in future (for eg. uterine cells,
CVS) which might provide more unequivocal answers to the
relative expression of CAG longer alleles and subsequent
hyperandrogenic condition in RSA. Nevertheless, except in
experimental situations including a couple of samples, it may not
be feasible to obtain specific tissue samples especially in the Indian
situation.
Individual analysis of the hospital-specific samples also
yielded similar results to that of the pooled cohort, suggesting
internal consistency in the data. Unfortunately, we could not
obtain the serum androgen profiles of the cases in our study to
verify if the biochemical hyperandrogenism is involved in the
manifestation of RSA. Nevertheless, our study qualifies to
provide the genetic evidence for possible biochemical hyperan-
drogenism [1,2] as we could establish strong association of
longer CAG repeat length with the RSA suggesting a possible
endocrine aetiology of RSA. Further, while there was no
significant difference in the CAG allele distribution patterns
between the two abortion categories of our study, a highly
significant difference was observed for CAG alleles with
biallelic mean $21 repeats when these groups were separately
compared with the controls. The higher abortion category
exhibited a greater degree of difference with the controls which
implies that longer CAG alleles may predispose women with a
higher risk for spontaneous abortions.
In conclusion we may say that this maiden investigation of the
CAG repeat polymorphism in RSA provides strong evidence of
association of the longer CAG alleles with RSA, opening up the
possibility of employing this as a meaningful prognostic genetic
marker for identification of RSA cases. However, it is necessary to
replicate and establish this association in other populations of the
region before its prognostic value can be suggested with certainty.
Further genetic and physiological (functional) studies are also
required to ascertain the precise role of CAG polymorphism in the
manifestation of this disorder, which may help in developing
relevant endocrine therapeutic strategies for prevention of further
miscarriages.
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Figure S1 Distribution of CAG biallelic mean and longer alleles
in RSA cases with $3 abortions and controls.
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Figure S2 Distribution of CAG X_weighted_biallelic mean in
RSA cases and controls.
(TIF)
Figure 4. X-inactivation patterns in RSA cases and controls.
doi:10.1371/journal.pone.0017718.g004
Table 5. Distribution (%) of RSA cases and controls according
to the qualitative categories of CAG X-weighted biallelic
mean.
CAG X-weighted Biallelic Mean Cases (N=117) Controls (N=224)
,19 41.02 45.5
19 17.9 15.1
.19 41.02 39.2
x2 = 0.779, df = 2, p = 0.677.
doi:10.1371/journal.pone.0017718.t005
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